KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Depreciation and Depletion: 2015-2025

Historic Depreciation and Depletion for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $6.8 million.

  • Medpace Holdings' Depreciation and Depletion fell 4.82% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 1.27%. This contributed to the annual value of $27.8 million for FY2024, which is 15.25% up from last year.
  • Medpace Holdings' Depreciation and Depletion amounted to $6.8 million in Q3 2025, which was up 0.53% from $6.8 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Depreciation and Depletion peaked at $7.2 million during Q3 2024, and registered a low of $3.8 million during Q1 2021.
  • For the 3-year period, Medpace Holdings' Depreciation and Depletion averaged around $6.6 million, with its median value being $6.7 million (2025).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first skyrocketed by 55.40% in 2021, then fell by 4.82% in 2025.
  • Over the past 5 years, Medpace Holdings' Depreciation and Depletion (Quarterly) stood at $4.2 million in 2021, then grew by 21.17% to $5.1 million in 2022, then rose by 26.62% to $6.4 million in 2023, then climbed by 11.26% to $7.1 million in 2024, then declined by 4.82% to $6.8 million in 2025.
  • Its Depreciation and Depletion was $6.8 million in Q3 2025, compared to $6.8 million in Q2 2025 and $6.7 million in Q1 2025.